man hiking

Developing Regenerative Therapies that Reverse Chronic Disease

Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of cell therapies designed to reverse disease and promote the regeneration of damaged tissue.

Learn more about our approach
Woman hiking
Cell rendering up close
scientific data icon

Mission-Driven Science

Our proprietary CD34+ cell therapy platform has generated a multi-product development pipeline with the potential to provide curative therapies to people in need. 

Science
Scientist in Gloves Using Micro Pipette
lightbulb icon

Spotlight

We’re working on the development of cell therapies that could help many people in need and restore health. 

We combine deep scientific experience with a passion for changing the lives of patients.

Spotlight
Visualization of the heart vessels
Monitor Showing EKG Reading
electrocardiogram close up
publication icon

Publications

arrow-left
arrow-right

CD34+ Cell Therapy Significantly Reduces Adverse Cardiac Events, Health Care Expenditures, and Mortality in Patients with Refractory Angina

Testing for Coronary Microvascular Dysfunction

Autologous CD34+ Cell Therapy for Ischemic Tissue Repair

Library

Recent News

Join Our Team

Our mission is to discover, develop and deliver innovative therapeutics in areas of unmet medical need that improve patient lives. We can accomplish that goal through the collective efforts of talented individuals who work together to advance scientific research. We place a premium on integrity, respect, diversity and collaboration. These values have helped us to build a growing company that offers professionally rewarding careers with the opportunity to make a meaningful contribution to patients in need. 

Audience Applauding Speaker After Conference Presentation